Sirio to venture into personalised women’s health platform at Vitafoods Europe

Sirio Pharma, a global nutraceutical contract development and manufacturing organization (CDMO), will unveil a comprehensive women’s health platform at Vitafoods Europe. This portfolio, consisting of 25 formulations, caters to women’s health needs and stages from puberty to post-menopause.

Utilizing its global R&D capabilities, Sirio simultaneously introduced this premium range, incorporating branded ingredients, consumer trends, clinical data, and stability studies.

Highlighted at Vitafoods Europe will be three-star products, including the pioneering "MenoBalance" Gummy. Powered by Novasoy, a soy isoflavone from ADM, it addresses menopausal symptoms. This marks the successful delivery of Novasoy in a gummy for the first time, promising both functional benefits and enjoyment.

Moreover, post-natal and prenatal formulations featuring branded ingredients from KD Nutra and Gnosis by Lesaffre will be showcased. These products aim to address specific health concerns during and after pregnancy.

Sirio’s women’s health platform reflects a commitment to delivering premium products backed by robust scientific evidence, meeting the evolving wellness needs of female consumers.